Selank is a synthetic peptide analogue of the natural immunomodulator tuftsin, developed in Russia and studied there as an approved anxiolytic product. Like Semax, it lacks FDA or EMA approval and is sold elsewhere as a research compound.
Benefits
Selank is a synthetic heptapeptide, a modified analog of the endogenous immunomodulator tuftsin. It has real Russian human trial data, including a head-to-head comparison against an actual benzodiazepine.
Vs. medazepam, generalized anxiety disorder and neurasthenia (human, n=62 — 30 on Selank, 32 on medazepam): Selank produced anxiolytic effects similar to medazepam on standard anxiety scales (Hamilton, Zung, Clinical Global Impression), with an additional antiasthenic (anti-fatigue) effect medazepam didn't show. The anxiety improvement correlated with a specific biological marker (increased leu-enkephalin activity), suggesting a real physiological mechanism behind the clinical effect, not just a subjective one. Zozulya et al., Zh Nevrol Psikhiatr Im S S Korsakova, 2008 This trial is part of the evidence base Russian regulators used to approve Selank for these indications.
Mechanism: proposed to act via allosteric modulation of GABA-A receptors (similar target family to benzodiazepines, different binding site), enkephalinase inhibition, and BDNF upregulation.
Dosage
The Zozulya trial doesn't specify an exact per-dose figure in what's available here — worth pulling the full paper before publishing a specific number. No dependence or withdrawal was reported across trials up to 28 days, per secondary reporting not independently verified in this pass.
Side Effects
The head-to-head trial reports Selank as comparably tolerated to medazepam, with the notable advantage of not producing the sedation/dependence profile associated with benzodiazepines — though this specific comparative safety claim wasn't independently re-verified against the full paper's adverse-event data in this pass.
Is Selank approved anywhere?+
It has regulatory approval in Russia, but not from the FDA or EMA.
What is Selank researched for?+
Anxiety-related and mood research is the most common focus, alongside some immune-modulation studies.
Is Selank a stimulant?+
No, it is studied as an anxiolytic (anti-anxiety) compound rather than a stimulant.
What's the actual difference between Semax and Selank?+
They're often grouped together, but they do different jobs. Semax leans toward cognitive activation — focus, drive, BDNF-driven neuroplasticity. Selank leans toward calm — anxiolytic, working through GABA and serotonin pathways rather than the dopamine/BDNF route Semax uses.
Is Selank basically a natural benzodiazepine?+
Not really, and that's the interesting part. It increases how sensitive your inhibitory GABA-A receptors are to GABA itself, rather than forcing the receptor open the way benzodiazepines do — which is the mechanistic reason it isn't associated with the same sedation, dependency, or tolerance issues.
Why do people stack it with Semax?+
Because the mechanisms don't overlap — Semax activates and sharpens focus, Selank calms and steadies, and running them together is one of the most common nootropic peptide pairings for exactly that complementary reason.
Does it affect mood beyond just anxiety?+
There's a real mechanism for it — Selank slows the breakdown of enkephalins, your body's natural opioid-like peptides that influence mood and pain perception, part of why it's discussed for mood stabilization beyond pure anxiety relief.
Looking for something specific, or placing a wholesale order? Send us a DM or email.